Glucophage

Glucophage is a prescription medication that contains the active ingredient metformin hydrochloride. It is classified as a biguanide oral antidiabetic drug, typically supplied in tablet form, though specific strength and dosage form may vary across the European market. Glucophage works by lowering hepatic glucose production, decreasing intestinal glucose absorption, and enhancing peripheral insulin sensitivity, making it a core therapy for managing type 2 diabetes mellitus patients.

Glucophage is indicated for the long‑term management of hyperglycemia in adults with type 2 diabetes mellitus, typically as part of a comprehensive treatment plan that includes diet and exercise.

- Used as monotherapy when diet and exercise alone do not achieve glycemic control. - Combined with other oral antidiabetic agents such as sulfonylureas or thiazolidinediones. - May be prescribed alongside basal insulin in patients requiring additional glucose lowering. - Considered for use in overweight or obese patients to aid weight management. - Employed to reduce the risk of diabetes‑related microvascular complications when glycemic targets are met.

The safety profile of Glucophage includes a range of adverse effects that vary in frequency and severity.

Common: - Gastrointestinal upset such as nausea, abdominal discomfort, or diarrhea. - Metallic taste in the mouth. - Decreased appetite or mild weight loss. - Vitamin B12 deficiency with prolonged use.

Serious: - Lactic acidosis, a rare but potentially fatal metabolic complication. - Severe hypoglycemia when combined with insulin or insulin secretagogues. - Acute pancreatitis presenting with abdominal pain and elevated enzymes.

Before initiating Glucophage, clinicians should evaluate several clinical factors to minimize risks and ensure appropriate use.

- Assess renal function; contraindicated in patients with severe renal impairment. - Review hepatic status, as liver disease may increase lactic acidosis risk. - Monitor for signs of heart failure, especially during dose escalation. - Evaluate for alcohol abuse, which can potentiate lactic acidosis. - Check baseline vitamin B12 levels and re‑check periodically. - Use caution in elderly patients due to higher susceptibility to adverse effects. - Discontinue before any radiographic studies using iodinated contrast agents.

Glucophage can interact with other medicines, affecting its efficacy or increasing the likelihood of adverse reactions.

Avoid: - Concurrent use with iodinated contrast media without appropriate interruption. - Co‑administration with potent CYP450 inhibitors that may alter metformin clearance. - Combining with high‑dose alcohol intake.

Use with caution: - Sulfonylureas or insulin, which may increase hypoglycemia risk. - Cimetidine, which can raise metformin plasma concentrations. - Diuretics that may affect renal function and metformin excretion. - Corticosteroids, which can raise blood glucose levels.